Literature DB >> 31179104

Simple pre-procedure risk stratification tool for contrast-induced nephropathy.

Zhonghan Ni1, Yan Liang2, Nianjin Xie1, Jin Liu1, Guoli Sun1, Shiqun Chen1, Jianfeng Ye3, Yibo He1, Wei Guo1, Ning Tan1, Jiyan Chen1, Yong Liu1, Zhujun Chen1, Shouhong Wang4.   

Abstract

BACKGROUND: A few simple and pre-procedural risk models have been developed for predicting contrast-induced nephropathy (CIN), which allow for early administration of preventative strategies before coronary angiography (CAG). The study aims to develop and validate simple pre-procedure tools for predicting risk of CIN following CAG.
METHODS: We retrospectively analyzed the data from 3,469 consecutive patients undergoing CAG, who were randomly assigned to a development dataset (n=2,313) and a validation dataset (n=1,156). CIN was defined as an increase in serum creatinine (SCr) ≥0.5 mg/dL from baseline within 72 hours after CAG. Multivariate logistic regression was applied to identify independent predictors of CIN to develop risk models. The possible predictors included age >75 years, hypotension, acute myocardial infarction (AMI), SCr ≥1.5 mg/dL, and congestive heart failure (CHF).
RESULTS: The incidences of CIN were 3.20% and 3.55% in the training and validation dataset respectively. Compared to classical Mehran' and ACEF CIN risk score, the new score across the validation dataset exhibited similar discrimination and predictive ability on CIN (c-statistic: 0.829, 0.832, 0.812 respectively) and in-hospital mortality (c-statistic: 0.909, 0.937, 0.866 respectively) (all P>0.05).
CONCLUSIONS: The easy-to-use pre-procedural prediction model only containing 5 factors had similar predictive ability on CIN and mortality.

Entities:  

Keywords:  Contrast-induced nephropathy (CIN); coronary angiography (CAG); percutaneous coronary intervention; risk score

Year:  2019        PMID: 31179104      PMCID: PMC6531701          DOI: 10.21037/jtd.2019.04.69

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  27 in total

1.  Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.

Authors:  Eric Chong; Kian Keong Poh; Shen Liang; Huay Cheem Tan
Journal:  Ann Acad Med Singap       Date:  2010-05       Impact factor: 2.473

2.  Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score.

Authors:  Jin Wi; Young-Guk Ko; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Jong-Won Ha; Myeong-Ki Hong; Yangsoo Jang
Journal:  Clin Cardiol       Date:  2012-10-01       Impact factor: 2.882

3.  The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Authors:  Nicklaus K Slocum; P Michael Grossman; Mauro Moscucci; Dean E Smith; Herbert D Aronow; Simon R Dixon; David Share; Hitinder S Gurm
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

4.  Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.

Authors:  Dimitrios Tziakas; Georgios Chalikias; Dimitrios Stakos; Stavros Apostolakis; Thomaidi Adina; Petros Kikas; Apostolos Alexoudis; Ploumis Passadakis; Elias Thodis; Vassilis Vargemezis; Stavros Konstantinides
Journal:  Int J Cardiol       Date:  2013-02-10       Impact factor: 4.164

5.  Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.

Authors:  Charanjit S Rihal; Stephen C Textor; Diane E Grill; Peter B Berger; Henry H Ting; Patricia J Best; Mandeep Singh; Malcolm R Bell; Gregory W Barsness; Verghese Mathew; Kirk N Garratt; David R Holmes
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

6.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Authors:  Giancarlo Marenzi; Gianfranco Lauri; Emilio Assanelli; Jeness Campodonico; Monica De Metrio; Ivana Marana; Marco Grazi; Fabrizio Veglia; Antonio L Bartorelli
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

7.  Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.

Authors:  Mauro Maioli; Anna Toso; Michela Gallopin; Mario Leoncini; Delio Tedeschi; Carlo Micheletti; Francesco Bellandi
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-06       Impact factor: 2.160

8.  [Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis].

Authors:  Alberto Bouzas-Mosquera; José Manuel Vázquez-Rodríguez; Ramón Calviño-Santos; Jesús Peteiro-Vázquez; Xacobe Flores-Ríos; Raquel Marzoa-Rivas; Pablo Piñón-Esteban; Guillermo Aldama-López; Jorge Salgado-Fernández; Nicolás Vázquez-González; Alfonso Castro-Beiras
Journal:  Rev Esp Cardiol       Date:  2007-10       Impact factor: 4.753

9.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.

Authors:  Beth A Bartholomew; Kishore J Harjai; Srinivas Dukkipati; Judith A Boura; Michael W Yerkey; Susan Glazier; Cindy L Grines; William W O'Neill
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

10.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

View more
  7 in total

1.  Sometimes neither water nor fire are more useful than friendship-a new risk score for prediction of contrast-induced nephropathy (CIN) and long-term adverse outcomes in patients undergoing coronary angiography.

Authors:  Ovidio De Filippo; Fabrizio D'Ascenzo; Francesco Piroli; Carlo Budano; Gaetano Maria De Ferrari
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

2.  Erratum to simple pre-procedure risk stratification tool for contrast-induced nephropathy.

Authors:  Zhonghan Ni; Yan Liang; Nianjin Xie; Jin Liu; Guoli Sun; Shiqun Chen; Jianfeng Ye; Yibo He; Wei Guo; Ning Tan; Jiyan Chen; Yong Liu; Zhujun Chen; Shouhong Wang
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

3.  ACEF performed better than other risk scores in non-ST-elevation acute coronary syndrome during long term follow-up.

Authors:  Ivica Kristić; Mislav Vrsalovic; Nikola Crnčević; Frane Runjić; Vesna Čapkun; Ozren Polašek; Andrija Matetic
Journal:  BMC Cardiovasc Disord       Date:  2021-02-03       Impact factor: 2.298

4.  Endorsement of the TRIPOD statement and the reporting of studies developing contrast-induced nephropathy prediction models for the coronary angiography/percutaneous coronary intervention population: a cross-sectional study.

Authors:  Simeng Miao; Chen Pan; Dandan Li; Su Shen; Aiping Wen
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

5.  A comparison between two different definitions of contrast-associated acute kidney injury for long-term mortality in patients with diabetes undergoing coronary angiography: a prospective cohort study.

Authors:  Zhubin Lun; Li Lei; Dianhua Zhou; Ming Ying; Liwei Liu; Guanzhong Chen; Jin Liu; Yibo He; Huanqiang Li; Zhidong Huang; Yongquan Yang; Jianfeng Ye; Yong Liu
Journal:  BMC Cardiovasc Disord       Date:  2020-11-16       Impact factor: 2.298

Review 6.  The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy.

Authors:  Eunjung Cho; Gang-Jee Ko
Journal:  Diagnostics (Basel)       Date:  2022-01-12

7.  The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients.

Authors:  Zhubin Lun; Liwei Liu; Guanzhong Chen; Ming Ying; Jin Liu; Bo Wang; Jingjing Liang; Yongquan Yang; Shiqun Chen; Yibo He; Edmund Y M Chung; Jiyan Chen; Jianfeng Ye; Yong Liu
Journal:  J Nephrol       Date:  2021-06-02       Impact factor: 3.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.